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Ogden syndrome is a rare lethal X-linked recessive disorder caused by a recurrent
missense variant (Ser37Pro) in the NAA10 gene, encoding the catalytic subunit of the
N-terminal acetyltransferase A complex (NatA). So far eight boys of two different
families have been described in the literature, all presenting the distinctive and recog-
nizable phenotype, which includes mostly postnatal growth retardation, global severe
developmental delay, characteristic craniofacial features, and structural cardiac
anomalies and/or arrhythmias. Here, we report the ninth case of Ogden syndrome
with an independent recurrence of the Ser37Pro variant. We were able to follow the
clinical course of the affected boy and delineate the evolving phenotype from his
birth until his unfortunate death at 7 months. We could confirm the associated phe-
notype as well as the natural history of this severe disease. By describing new pre-
senting features, we are further expanding the clinical spectrum associated with
Ogden syndrome and review other phenotypes associated with NAA10 variants.
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1 | INTRODUCTION
Ogden syndrome, was named after the hometown of the first family
observed by John M. Opitz with an X-linked recessive disorder character-
ized by early lethality due to structural cardiac anomalies and/or arrhyth-
mias, severe global developmental delay, postnatal growth retardation,
and prematurely aged appearance with reduced subcutaneous adipose
tissue and redundant skin (Lyon, 2011; Maffly, 2012; Rope et al., 2011;
Wu & Lyon, 2018). In 2011, it was identified as the first human genetic
disorder associated with a variant in an N-terminal acetyltransferase
(NAT) (Rope et al., 2011). So far, only the original eight affected males
from two different families are described in the literature, all harboring
the same missense variant, a Ser37Pro, in the gene encoding NAA10, the
catalytic subunit of the N-terminal acetyltransferase A complex (NatA),
the major human NAT involved in the co-translational acetylation of pro-
teins (Arnesen et al., 2005; Rope et al., 2011). Nevertheless, further phe-
notypes in males and females have been described with other pathogenic
variants resulting in the suggestion of the broader term NAA10-related
syndrome (Wu & Lyon, 2018). We now report an independent recur-
rence of the Ser37Pro variant further supporting the initially described
genotype–phenotype relation with the Ogden syndrome clinical course
and also expanding its clinical signs.
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2 | CLINICAL REPORT
This male infant was born to healthy, non-consanguineous parents of
German and Polish origin. He was the first child of the 40-year-old
mother, who had one miscarriage before. The mother had no obvious
anomalies, has a high educational attainment (University degrees in
economics and psychology), and runs her own business. Paternal age
at birth was 57 and his history was unremarkable. The pregnancy was
complicated by intrauterine growth retardation (IUGR). An abnormal
cardiotocography (CTG) lead to the induction of labor at gestational
week 37. His birth weight was 2580 g (1SD), his birth length was
43 cm (3SD), and his occipital frontal circumference measured
32.5 cm (1SD). Apgar scores were 9/9/10. The neonatal
examination revealed severe muscular hypotonia and a number of
distinctive morphologic signs, in particular the progeroid facial appear-
ance. After 48 h, he was transferred to the neonatal intensive care
unit (NICU) because of respiratory distress, feeding difficulties, and
hyperbilirubinemia. Clinical genetic evaluation of the 3-day-old boy
showed facial wrinkling and hirsutism, extension of hair growth on
temples to lateral eyebrow, prominent eyes, short and down-slanting
palpebral fissures, apparent hypertelorism, wide nasal bridge, promi-
nent nose, short columella, wide philtrum and mouth, high, narrow
palate, thick lingual frenulum, gingival overgrowth, thin upper lip ver-
milion in frontal view and microretrognathia. The ears were large,
low-set, posteriorly rotated and dysplastic with prominent crus of
helix and a large earlobe. In addition, a stenosis of the external
F IGURE 1 Prenatal ultrasound scans (a-c) and pictures of our patient at 3 days (d–j), 4 (k and l), and 6 months (m–n) showing the facial
apprearance and illustrating the changing phenotype. Note the facial wrinkling, proptosis, hypertelorism, wide nasal bridge, prominent nose, short
columella, deep philtrum, wide mouth, everted lower lip vermilion, and microretrognathia. The ears are large, low-set, malformed, and posteriorly
rotated. The fingers are long with mild camptodactyly. Long toes with broad halluces, sandal gap. Note the overall wrinkled loose skin with
decrease of subcutaneous fat. Some of the facial features such as apparent hypertelorism, broad nasal root, prominent nose with wide nares and
mouth, microretrognathia are already recognizable on prenatal 3D ultrasound scans
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auditory canals was observed and he failed the otoacoustic emissions
screening. He had a low posterior hair line and a short neck. Nipples
were hypoplastic and wide-spaced. The fingers were long, the thumbs
adducted. Mild camptodactyly and neonatally prominent fingertip
pads were noticed. His toes were long, halluces were broad with a
sandal gap. He had generalized hirsutism. The overall wrinkled and
redundant skin with reduced subcutaneous adipose tissue resulted in
a prematurely aged appearance (see Figure 1). The echocardiography
revealed an atrial septal aneurysm, a persistent foramen ovale, and a
bicuspid aortic valve. The chest X-ray demonstrated cardiomegaly and
scoliosis (see Figure 2). The eye examination showed persistent pupil-
lary membranes, an enlarged and oval-shaped optic disc anomaly and
peripheral retinal hyperpigmentation in both eyes. An ultrasound of
the hip and the groin confirmed congenital bilateral hip dislocation
and unilateral acetabular dysplasia. The abdominal ultrasound was
normal. His clinical course was complicated by failure to thrive, fre-
quent desaturations, and hypoglycemia, requiring support with tube
feeding, high flow therapy and supplemental nutrition. A diagnosis of
Donohue syndrome was considered but insulin levels were normal.
After he spent approximately 4 weeks in NICU, tube feeding and
monitoring of his oxygen saturation were continued at home. At
6 weeks of age he presented again to the pediatric emergency care
with an upper respiratory infection. His weight was 3.05 kg (2SD).
He was discharged from the hospital the same day. At the 9-weeks
follow-up, his weight was 3.66 kg (3SD) and his head circumference
was 36 cm (4SD). No further hypoglycemia was noted. Elective hos-
pital admission for percutaneous endoscopic gastrostomy was con-
ducted at the age of 15 weeks. The Cormnack Lehane score III
predicted a difficult airway management due to a bulging mass in the
epipharynx and fiberoptic intubation was performed. After
the intervention he suffered from apneic episodes which lead to an
urgent transfer to the NICU. In the following days he suffered from a
number of serious complications, including pneumothorax, and several
infections (i.e., pneumonia, urinary tract infection, and gastroenteritis).
In addition, he developed epileptic seizures, the EEG showed patho-
logic monomorphic patterns with absence of epileptiform activity.
Brain imaging by magnetic resonance imaging (MRI) was performed
and revealed enlarged ventricles, a slender corpus callosum, a small
pituitary gland, and white matter reduction. The MRI confirmed fur-
ther the previously noticed craniofacial traits of the viscerocranium,
that is, hypertelorism, retrognathia, and deviated nasal septum. In
addition, the MRI revealed an adipose tissue mass (DD: teratoma)
compressing the epipharynx (see Figure 2). Unfortunately, no histolog-
ical analysis of this tissue mass was undertaken. The boy underwent
extubation after 10 days at the NICU and needed further assisted
respiratory ventilation (CPAP-therapy) for additional 10 days. Due to
the complications and the intermittent desaturations, he was hospital-
ized for almost 5 weeks. The following weeks his general condition
fortunately ameliorated; he started to interact with his environment
and was able to fixate objects or persons. The severe truncal hypoto-
nia improved under physiotherapy and craniosacral therapy. Surpris-
ingly he showed a remarkable change in the phenotype. He appeared
less aged and the facial wrinkling was less prominent, but no Holter or
telemetry-monitoring was done. His weight, length and head circum-
ference remained, however, below the third centile at 4 months of
age. Following the molecular diagnosis of Ogden syndrome, a stan-
dard electrocardiogram was performed at the ages of 2 weeks and
4 months which revealed no abnormalities. At 6 months of age he
was hospitalized a third time with respiratory distress, severe
coughing, and vomiting. His general condition was slightly reduced,
F IGURE 2 (a) Magnetic resonance imaging of the brain revealed intracranially wide inner and outer cerebrospinal fluid spaces and a very
narrow corpus callosum. Note the increased fatty tissue in the epipharynx (grey arrow). (b) X-ray of the chest showing cardiomegaly, scoliosis and
paravertebral left residual consolidation with positive air bronchogram
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but he did not appear to be very sick. Initially the respiratory condition
could be stabilized, however an increasing agitation and irritability
made the respiratory support difficult. Overnight his condition deteri-
orated rapidly. He was unable to maintain adequate ventilation and
displayed agonal respiration and severe desaturations (O2 level: 45%).
A high flow ventilation was initiated, and the sedation was augmented
by a subcutaneous morphine pump. Because he did not respond to
morphine, midazolam was administered. He became more and more
agitated and did not tolerate the ventilation. Moreover, he developed
two generalized tonic seizures. He developed increased respiratory
distress resulting in respiratory acidosis and respiratory failure. Chest
X-rays revealed cardiomegaly, scoliosis, and paravertebral residual
consolidation with positive air bronchogram on the left side (see
Figure 2), but neither high-resolution lung CT-imaging nor lung biopsy
was performed. As his condition progressively worsened, his parents
chose to stop all life sustaining procedures. He died at the age of
7 months, probably due to complications of an obstructive bronchitis,
but no autopsy was undertaken.
3 | GENETIC STUDIES
Chromosomal microarray analysis using an Affymetrix Cytoscan HD
array with 2.65 million probes revealed normal results at a 20 kb reso-
lution. Whole exome sequencing was performed using the Agilent
SureSelectXT Clinical Research Exome Kit (V5) for capturing and
paired-end-sequencing (HiSeq SBS Kit v4, 125 Fwd-125 Rev,
Q30-value 90) on a HiSeq2500 sequencer (Illumina Inc.) resulting in
94.2% of the target region covered 20. Coding regions and
12 flanking intronic basepairs were analyzed for potentially deleteri-
ous variants in known disease genes using annotations of SIFT,
PhyloPhen, LRT, Mutation Taster, Mutation assessor, FATHMM,
GERP and CADD as provided by the NextGene Viewer (Softgenetics)
software. The only obviously pathogenic variant identified was the
hemizygous variant NM_003491.2(NAA10):c.[109T>C] p.[(Ser37Pro)]
chrX.hg19:g.[153199841T>C], rs387906701. The variant was con-
firmed by Sanger sequencing and also detected in the patient's
mother but excluded in the maternal grandmother (see Figure 3). X-
Inactivation studies using the trinucleotide-repeat of the AR-gene as
described (Lau et al. Am J Hum Genet [1997] 61:1353–1361) revealed
100% skewing in the mother's blood probe. X-inactivation studies at
the SLITRK4 locus (Xq27.3) (Bertelsen et al. J Mol Diagn [2011]
13:537–540) showed a random X-inactivation (48:52) in the blood
probe of the maternal grandmother, who is not a carrier.
4 | DISCUSSION
Our observation confirms the initial reports of Ogden syndrome as
an X-linked recessive early lethal condition in boys caused by the
NAA10 variant Ser37Pro (Rope et al., 2011). Because the two previ-
ously described families shared a surrounding haplotype of not more
than 1.5 cM, a founder variant was likely dismissed but could not be
excluded (Rope et al., 2011). Since the variant occurred de novo in
the boy's mother reported here, we can now unambiguously prove
this variant to be recurrent. While carrier women of this variant are
healthy with skewed X-inactivation, the phenotype of affected boys
is consistently severe (see Table 1) (Myklebust et al., 2015; Rope
et al., 2011). The prematurely aged appearance with facial wrinkling,
reduced subcutaneous adipose tissue and redundant skin is patho-
gnomonic for this syndrome (Rope et al., 2011). All affected boys
present the same facial anomalies such as prominent eyes, hyper-
telorism, downslanting palpebral fissures, broad philtrum, wide
mouth and microretrognathia, as well as large, low-set ears with
F IGURE 3 Partial electropherograms after Sanger sequencing of
PCR amplifications of exon 2 of NAA10 in our patient, his mother,
and grandmother


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GOGOLL ET AL. 7
abnormality of the pinna. As demonstrated in our case, some of
these facial features are already recognizable on prenatal 3D ultra-
sound scans (see Figure 1). A variety of prenatal complications
(e.g., IUGR, oligohydramnios, premature birth) were reported in
almost all affected pregnancies. Growth parameters at birth were,
except in our case, in the normal range, but in the further course
weight, length and head circumference were below the 5th centile
in five patients. Not all affected boys were described in great detail,
but the typical clinical course was characterized by postnatal compli-
cations, which required in most of the times neonatal intensive care,
particularly for respiratory distress and feeding difficulties. Muscular
hypotonia, mainly of the trunk was present in several affected boys
and some developed limb hypertonia. Cardiac anomalies were a per-
sistent finding in more than half of the boys and included ventricular
septal defect, atrial septal defect, pulmonary artery stenosis, and
bicuspid aortic valve. Cardiac arrhythmias occurred in four and
apneic episodes or desaturations in five patients. When specified, all
boys presented with moderate to severe global developmental
delay. Brain imaging, when undertaken, revealed various anomalies
(i.e., enlarged ventricles, cerebral atrophy, immature myelination) in
four boys and three boys developed seizures. Recurrent infections
were described in four boys. Cryptorchidism/small testes were diag-
nosed in five patients and four had inguinal or umbilical hernias.
While our patient showed persistent pupillary membrane, retinal
pigmentary anomalies and an anomalous optic disc, except for a
lagophthalmos no other eye anomalies were reported in the other
affected boys (Rope et al., 2011). Scoliosis was diagnosed in our
patient and in another boy (Rope et al., 2011). Our patient died at
the age of 7 months, which confirms again the so far described
lethal course of this syndrome. In our patient no cardiac arrhythmia
was detected, but only two standard electrocardiograms were per-
formed, which is not sufficient to exclude e.g. long QT-syndrome.
Premortal chest X-rays revealed cardiomegaly and signs of obstruc-
tive bronchitis (see Figure 2), but since autopsy was denied the
underlying cause of the respiratory failure was not fully understood.
Clinical findings that were only present in our patient were the bilat-
eral hip dislocation with an unilateral acetabular dysplasia,
the ophthalmological anomalies and the adipose tissue mass (DD:
teratoma) in the epipharynx.
Ogden syndrome was the first genetic syndrome linked to variant
in a NAT (Rope et al., 2011). The NAA10 gene is located on the X-
chromosome (Xq28), has an universal expression pattern in human fetal
and adult tissues, and encodes the catalytic subunit (NAA10) of NatA
and the auxiliary subunit of NatE (Lee et al., 2018b; Pang et al., 2011;
Park & Szostak, 1992; Tribioli et al., 1994). NATs catalyze the most
common modification of eukaryotic proteins, namely the acetylation of
proteins at their N-terminus by transferring an acetyl moiety from ace-
tyl coenzyme (Aksnes et al., 2016; Dörfel & Lyon, 2015; Friedmann &
Marmorstein, 2013; Polevoda et al., 2009; Starheim et al., 2012). NatA
is the major human NAT and is composed at least of the catalytic sub-
unit Naa10, the auxiliary subunit Naa15, NAA50 and HYPK (Arnesen
et al., 2005, 2006, 2010). NAA10 is mainly bound in complex with







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 GOGOLL ET AL.
Van Damme et al., 2011), yet there also exists a pool of non-NAA15
bound NAA10 (Van Damme et al., 2011).
The Ser37Pro missense variant is localized in exon 2 and has
been well studied in vitro and in vivo. The serine codon is highly con-
served in eukaryotes and lies within the dimerization domain with
Naa15 (see Table. 2) (Rope et al., 2011). The Ser37Pro variant
showed decreased enzymatic activity in in vitro acetylation assays,
reduced NatA-complex formation and an impaired interaction with
hNaa50, suggesting the lack of N-terminal-acetylation of a small
number of proteins (Myklebust et al., 2015; Rope et al., 2011). Fur-
thermore, S37P-hTERT cells have reduced cell proliferation and dys-
regulation regarding cell–cell contact inhibition and migration
(Myklebust et al., 2015). Lee et al. concluded that defects in DNA
methylation and genomic imprinting may have as well a contributory
role to the pathomechanism of Ogden syndrome, showing that the
Ser37Pro variant disrupts ICR binding of Naa10 and Dnmt1 (Lee
et al., 2018a).
No other case of Ogden syndrome has been published since it
was first described in 2011. But in 2018, Cheng et al. identified a de
novo hemizygous missense variant Arg10Gly in a 4.5 month-old boy
with an Ogden syndrome-like phenotype with remarkably similar
facial features and a severe, early lethal clinical course (Cheng
et al., 2020). Functional characterization showed that this variant has
similar cellular effects as the Ser37Pro variant, explaining the severe
lethal phenotype (Cheng et al., 2020). Wu and Lyon suggested that
the term Ogden syndrome should be reserved for male infants with
the fatal neonatal presentation (Wu & Lyon, 2018). Although the boy
had a fatal neonatal outcome the authors Cheng and Lyon did not
label this case as Ogden syndrome, maybe because the NAA10 variant
occurred de novo in this case and it was not totally clear if it was X-
linked recessive (Cheng et al., 2020). Thus, more detailed descriptions
of the fatal NAA10-related disorder are needed to fully understand
the genetic and clinical heterogeneity of Ogden-syndrome. After
uncovering Ogden syndrome in 2011, reports of different nonlethal
NAA10 variants in males as well as mostly de novo variants in
affected female index cases with nonspecific ID have been published,
expanding the clinical spectrum and elucidating the underlying com-
plexity of NAA10 deficiency (see Figure 4). An excellent overview of
these overlapping yet distinct disorders associated with pathogenic
variants in the NAA10 gene was published by Wu and Lyon, who rec-
ommend that these diseases should be referred to more broadly as
NAA10-related syndrome, given the enormous phenotypic variability
(Wu & Lyon, 2018). A comparative synopsis of the different clinical
presentations is depicted in Table 2, showing on the one hand the
large heterogeneity and on the other hand the consistency of the phe-
notype of NAA10-related syndrome, for example, developmental
delay ranging from mild to severe, muscular hyptonia, skeletal and
growth abnormalities, cardiac anomalies and recurrent infections. The
cause of the wide-ranging phenotypic differences, the disease pro-
gression and severity among different NAA10 variants, especially in
boys, is still a topic of debate. In 2012, Rauch et al. showed first that
another NAA10 de novo missense variant Arg116Trp can also cause a


























































































































































































































































































































































































































































































































































































































































































GOGOLL ET AL. 11
(Rauch et al., 2012). In vitro studies showed that this variant has a sig-
nificant but rather small reduction in the catalytic activity (15%) in
comparison to the Ser37Pro variant, a plausible explanation for the
mild phenotype in the boy (Popp et al., 2015). However, in 2015,
Casey et al. argued that the relation between Naa10 variants and dis-
ease phenotypes is more complex and that the in vitro catalytic activ-
ity in itself is not always sufficient in explaining phenotypes observed
in patients (Casey et al., 2015). The group identified a maternally
inherited missense variant Tyr43Ser in the NAA10 gene, resulting in a
severely impaired catalytic activity compared to the Ser37Pro variant,
in two affected brothers with intellectual disability, cardiac arrhythmia
including long QT, dysmorphic and skeletal features (syndromic ID)
(Casey et al., 2015). This assumption was supported by the group of
Ree et al., who identified a de novo NAA10 missense variant
Arg83His, leading to a greatly reduced catalytic activity due to
impaired Ac-CoA binding in two unrelated boys with intellectual dis-
ability, developmental delay, ADHD like behavior, very limited speech
and cardiac abnormalities (Ree et al., 2019). An additional possible
pathomechanism, referring to the different substrate specificity of
NAA10, was proposed by Stove et al., who published a previously
undescribed maternally inherited NAA10 variant Ile72Thr in three
boys from two unrelated families with a milder phenotypic spectrum
consisting of developmental delay, intellectual disability, cardiac
arrhythmia and hypertrophic cardiomyopathy (Stove et al., 2018).
Functional studies of this variant revealed an increased turnover rate
when expressed in human cell lines, a 75% reduction in catalytic activ-
ity toward the in vitro monomeric NAA10 substrate, but surprisingly
no reduction in catalytic activity when tested for the NatA substrate,
leading to the assumption that this Ile72Thr is protected from degra-
dation and destabilization by forming a functional NatA complex
(Stove et al., 2018). In summary these functional studies of NAA10
missense variants, demonstrating a variable effect on the ability of
NAA10 to acetylate substrates, are supporting the hypothesis that the
level of acetylation dysfunction and affected substrates is an impor-
tant underlying pathomechanism with a possible correlation toward
the clinical phenotype (Johnston et al., 2019).
Compared to missense variants, alterations in the NAA10 gene
which result in a (partial) loss of protein function due to reduced
mRNA levels can lead to syndromic microphthalmia/anophthalmia in
boys (Esmailpour et al., 2014; Johnston et al., 2019; Shishido
et al., 2020). Complete loss-of-function of NAA10, however, is
thought to be lethal in males (Popp et al., 2015).
F IGURE 4 Schematic representation of the genomic structure plus the functional domains of the human NAA10 gene with representation of
the genotype–phenotype correlation of the so far described NAA10 pathogenic variants in males (above NAA10 and NAA10) and in affected
females index cases (below NAA10). The genomic structure is based on isoform 1, encoded by transcript NM_003491.3. The domain structure
corresponds to the following Uniprot identifiers P41227
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The majority of variants in male patients were maternally
inherited and most of the female carriers were healthy or had only
minor features (see Table 2). But as already mentioned, female index
patients with pathogenic, apart from one maternal mosaic variant
merely de novo missense variants in the NAA10 gene have been
equally identified over the time. The phenotype in females with
NAA10-related N-terminal-acetyltransferase deficiency is among
others characterized by moderate to severe developmental delay and
ID with no or very limited speech, postnatal growth failure, micro-
cephaly, seizures, different skeletal, brain, and organ anomalies and
cardiac arrhythmias (see Table 2) (Bader et al., 2020; Cheng
et al., 2020; McTiernan et al., 2018; Popp et al., 2015; Saunier
et al., 2016; Sidhu et al., 2017; Thevenon et al., 2016).
X-chromosome inactivation studies in affected females, when
undertaken, were not conclusive, showing either random or skewed
X-inactivation. Studies of acetylation activity revealed severely
abolished activity in most but not all of these de novo variants causing
a severe phenotype in females (Cheng et al., 2020; Popp et al., 2015;
Saunier et al., 2016).
Ogden syndrome was the first genetic disorder which contributed
highly to the research and decipherment of the fascinating role of N-
terminal acetylation in development and disease. With the identifica-
tion of different NAA10 alterations, we slowly gain insight into its
complexity and are starting to unravel the contributing factors and
mechanism underlying this broad clinical spectrum of NAA10-related
disorders.
5 | CONCLUSION
In summary we presented the ninth case of a boy with Ogden syn-
drome who was diagnosed in Zurich, Switzerland more than
5000 miles away from the hometown of the original family in Utah,
USA. We could confirm the consistency of the clinical phenotype
and recurrence of this rare lethal X-linked recessive disorder cau-
sed by the NAA10 Ser37Pro variant. Our patient exhibited the full
phenotypic spectrum of Ogden syndrome (Aksnes et al., 2016),
which is a highly recognizable syndrome, in particular due to the
remarkable similar facial gestalt of affected boys. We further delin-
eated the evolving phenotype of this condition, additionally pres-
ented new clinical findings and reflected shortly on the extensive
phenotypic variability that is linked to different variants in the
NAA10 gene.
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